Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Victor Hwang: Individual entrepreneurs hold the key to making America great again
Victor Hwang posed a riddle to a TEDx crowd gathered in Georgia. What five-letter word was overlooked during the 2016 U.S. presidential campaign and almost never mentioned by the candidates or at the party conventions? The answer is rooted in overcoming inequality, said Hwang, vice president of entrepreneurship for the Ewing Marion Kauffman Foundation. “I’m…
Startup newbie: How researching entrepreneurship in Medellin led me to Kansas City
Editor’s note: The opinions expressed in this commentary are the author’s alone. When my wife Megan and I visited Kansas City this past January as part of our “city shopping tour,” there was much that impressed us and led to our decision to make it our new home. In many respects, we chose Kansas City…
Buildings and bus stops: Rebecca Tombaugh paints KC — sometimes with a stick
A lack of clear direction felt liberating as Rebecca Tombaugh unrolled a 12-foot piece of heavy paper in her backyard and got to work, she said. The 59-year-old artist had been tasked with painting a mural of sorts for the Nonprofit Village, a coworking spot that soon would open at 31 W. 31st Street. It’s…
KC-based PatientsVoices pulls $150K in first round of seed capital, additional $75K from MTC
Competing for a spot in a Nashville-based health tech accelerator, PatientsVoices landed its first round of seed capital — with a booster shot from the State of Missouri. A $150,000 innovation grant from Jumpstart Foundry investment group represents a leap forward for PatientsVoices, headquartered in iWerx’s North Kansas City entrepreneurial development center, said founder and…